GADOQUATRANE

UNII:	OZG7J613HK
Type:	INGREDIENT SUBSTANCE
Formula:	C₈₁H₁₂₈N₂₄O₃₂.₄Gd
Preferred Substance Name:	GADOQUATRANE
InChIKey:	HGIZCBUSWUYZEQ-UHFFFAOYSA-B
GSRS Full Record:	OZG7J613HK i

2048221-65-2
2-[4,10-bis(carboxylatomethyl)-7-[1-oxo-1-[[2-oxo-2-[[3-[[2-[2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]propanoylamino]acetyl]amino]-2,2-bis[[[2-[2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]propanoylamino]acetyl]amino]methyl]propyl]amino]ethyl]amino]propan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;tetrakis(gadolinium(3+))
2-[4,10-bis(carboxylatomethyl)-7-[1-oxo-1-[[2-oxo-2-[[3-[[2-[2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]propanoylamino]acetyl]amino]-2,2-bis[[[2-[2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]propanoylamino]acetyl]amino]methyl]propyl]amino]ethyl]amino]propan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;tetrakis(gadolinium(3+))
BAY-1747846
GADOQUATRANE [USAN]
Gadolinium, [μ4-[[10,10′-[[2,2-bis[[[2-[[1-(oxo-κO)-2-[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN1,κN4,κN7,κN10]propyl]amino]acetyl]amino]methyl]-1,3-propanediyl]bis[imino(2-oxo-2,1-ethanediyl)imino[1-methyl-2-(oxo-κO)-2,1-ethanediyl]]]bis[1,4,7,10-tetraazacyclododecane-1,4,7-triacetato-κN1,κN4,κN7,κN10,κO1,κO4,κO7]](12-)]]tetra-κN1,κN4,κN7,κN10,κO1,κO4,κO7]](12–)]]tetra-
Gadoquatrane
Gadoquatrane [WHO-DD]
Tetragadolinium [4,10-bis(carboxylatomethyl)-7-{3,6,12,15- tetraoxo-16-[4,7,10-tris- (carboxylatomethyl)-1,4,7,10- tetraazacyclododecan-1-yl]-9,9-bis({[({2-[4,7,10-tris- (carboxylatomethyl)-1,4,7,10-tetraazacyclododecan-1- yl]propanoyl}amino)acetyl]-amino}methyl)- 4,7,11,14- tetraazaheptadecan-2-yl}-1,4,7,10-tetraazacyclododecan-1- yl]acetate
gadoquatrane [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

GADOQUATRANE

Synonyms and Mappings

Resources